Related Experiment Video
Updated: Oct 3, 2025

12:03
The Production of C. elegans Transgenes via Recombineering with the galK Selectable Marker
Published on: January 11, 2011
14.7K
Genome Engineering in Mycoplasma gallisepticum Using Exogenous Recombination Systems
Thomas Ipoutcha1, Géraldine Gourgues1, Carole Lartigue1
1Univ. Bordeaux, INRAE, Biologie du Fruit et Pathologie, UMR 1332, F-33140 Villenave d'Ornon, France.
ACS Synthetic Biology
|February 15, 2022
Summary
Researchers developed new genetic tools for Mycoplasma gallisepticum (Mgal), a poultry pathogen. This breakthrough enables gene inactivation and targeted genome engineering in Mgal, advancing studies on its virulence and host specificity.
Area of Science:
- Microbiology
- Genomics
- Bacteriology
Background:
- Mycoplasma gallisepticum (Mgal) is a significant poultry pathogen with recent host shifts.
- Understanding Mgal virulence and host specificity is limited by a lack of functional genomics methods.
Purpose of the Study:
- To develop and validate efficient genetic tools for targeted genome engineering in Mgal.
- To establish methods for gene inactivation and replacement in Mgal.
Main Methods:
- Evaluation of two exogenous recombination systems (RecET-like from Bacillus subtilis and Cre-lox).
- Successful gene inactivation and targeted replacement in Mgal using the RecET-like system.
- Utilized Cre-lox system for antibiotic resistance marker removal in recombinant mutants.
Main Results:
- The RecET-like system from B. subtilis proved effective for gene inactivation and targeted replacement in Mgal.
- The Cre-lox system efficiently removed antibiotic resistance markers in engineered Mgal.
- Demonstrated the utility of heterologous recombination systems in minimal bacteria.
Conclusions:
- This study presents the first genetic tool for targeted genome engineering of Mgal.
- The developed tools will facilitate research into Mgal virulence and host specificity.
- Highlights the successful application of heterologous recombination systems in minimal bacterial pathogens.

